3D PRINTING TECHNOLOGIES USED IN PHARMA
Fuente:
Zenodo
Enregistré dans:
| Auteur principal: | |
|---|---|
| Format: | Recurso digital |
| Publié: |
Zenodo
2026
|
| Accès en ligne: | |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
| _version_ | 1866901389881376768 |
|---|---|
| author | Ms. Shinde Amruta Nilesh and Miss. Shirke S.S |
| author_facet | Ms. Shinde Amruta Nilesh and Miss. Shirke S.S |
| contents | <div> <p class="MsoNormal"><em><span>Three-dimensional<span> </span>(3D)<span> </span>printing<span> </span>has<span> </span>emerged<span> </span>as<span> </span>a<span> </span>transformative<span> </span>manufacturing technology in the pharmaceutical field, enabling the production<span> </span>of personalized, precise, and complex drug dosage forms. Various 3D printing techniques— including fused deposition modeling (FDM), stereolithography<span> </span>(SLA), selective laser sintering (SLS), inkjet printing, binder jetting, and semi-solid extrusion— allow controlled deposition of materials to fabricate patient-specific medicines with tailored dose, release kinetics, and geometry. These techniques support innovations<span> </span>such<span> </span>as<span> </span>polypills,<span> </span>rapid-dissolving<span> </span>tablets,<span> </span>modified-release<span> </span>systems, and<span> </span>implants.<span> </span>The<span> </span>first<span> </span>FDA-approved<span> </span>3D-printed<span> </span>drug,<span> </span>Spritam®,<span> </span>demonstrated the clinical relevance of this technology. Advantages include on-demand manufacturing, high customization, and improved therapeutic outcomes. However, challenges such as limited pharmaceutical-grade printable materials, regulatory uncertainties, scale-up issues, and quality-control requirements continue to restrict widespread adoption. Overall, 3D printing represents a promising platform for advancing personalized medicine and redefining pharmaceutical manufacturing.</span></em></p> <p class="MsoNormal"><em><span>Keywords :-3D<span> </span>printing,<span> </span>Additive manufacturing, Personalized medicine, Fused deposition modeling (FDM), Stereolithography (SLA), Digital light processing (DLP),<span> </span>Selective<span> </span>laser<span> </span>sintering<span> </span>(SLS),<span> </span>Inkjet<span> </span>printing,<span> </span>Binder<span> </span>jetting,<span> </span>Semi-solid <span>extrusion.</span></span></em></p> </div> |
| format | Recurso digital |
| id | zenodo_https___doi_org_10_5281_zenodo_19737253 |
| institution | Zenodo |
| language | |
| publishDate | 2026 |
| publisher | Zenodo |
| record_format | zenodo |
| spellingShingle | 3D PRINTING TECHNOLOGIES USED IN PHARMA Ms. Shinde Amruta Nilesh and Miss. Shirke S.S <div> <p class="MsoNormal"><em><span>Three-dimensional<span> </span>(3D)<span> </span>printing<span> </span>has<span> </span>emerged<span> </span>as<span> </span>a<span> </span>transformative<span> </span>manufacturing technology in the pharmaceutical field, enabling the production<span> </span>of personalized, precise, and complex drug dosage forms. Various 3D printing techniques— including fused deposition modeling (FDM), stereolithography<span> </span>(SLA), selective laser sintering (SLS), inkjet printing, binder jetting, and semi-solid extrusion— allow controlled deposition of materials to fabricate patient-specific medicines with tailored dose, release kinetics, and geometry. These techniques support innovations<span> </span>such<span> </span>as<span> </span>polypills,<span> </span>rapid-dissolving<span> </span>tablets,<span> </span>modified-release<span> </span>systems, and<span> </span>implants.<span> </span>The<span> </span>first<span> </span>FDA-approved<span> </span>3D-printed<span> </span>drug,<span> </span>Spritam®,<span> </span>demonstrated the clinical relevance of this technology. Advantages include on-demand manufacturing, high customization, and improved therapeutic outcomes. However, challenges such as limited pharmaceutical-grade printable materials, regulatory uncertainties, scale-up issues, and quality-control requirements continue to restrict widespread adoption. Overall, 3D printing represents a promising platform for advancing personalized medicine and redefining pharmaceutical manufacturing.</span></em></p> <p class="MsoNormal"><em><span>Keywords :-3D<span> </span>printing,<span> </span>Additive manufacturing, Personalized medicine, Fused deposition modeling (FDM), Stereolithography (SLA), Digital light processing (DLP),<span> </span>Selective<span> </span>laser<span> </span>sintering<span> </span>(SLS),<span> </span>Inkjet<span> </span>printing,<span> </span>Binder<span> </span>jetting,<span> </span>Semi-solid <span>extrusion.</span></span></em></p> </div> |
| title | 3D PRINTING TECHNOLOGIES USED IN PHARMA |
| url | https://doi.org/10.5281/zenodo.19737253 |